Litigation Details for OREXO AB v. SUN PHARMACEUTICALS INDUSTRIES LIMITED (D.N.J. 2020)
✉ Email this page to a colleague
OREXO AB v. SUN PHARMACEUTICALS INDUSTRIES LIMITED (D.N.J. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-09-11 |
Court | District Court, D. New Jersey | Date Terminated | 2023-07-20 |
Cause | 35:271 Patent Infringement | Assigned To | Zahid Nisar Quraishi |
Jury Demand | Referred To | Douglas Arpert | |
Patents | 8,940,330; 9,259,421; 9,439,900 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in OREXO AB v. SUN PHARMACEUTICALS INDUSTRIES LIMITED
Details for OREXO AB v. SUN PHARMACEUTICALS INDUSTRIES LIMITED (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-01-25 | 340 | Order | weak acid” in US. Patent Nos. 8,940,330 (“the ‘330 patent”), 9,259,421 (“the ‘421 patent”), 9,439,900 (“…(“the ‘900 patent”), 10,874,661 (“the ‘661 patent”), 10,946,010 (“the ‘010 patent”), 11,020,387 (“the…of 2 PagelD: 13528 . ‘388 patent”) (collectively, the “patents-in-suit”)' is construed to mean an…the ‘387 patent”), and 11,020,388 (“the Case 3:20-cv-12588-GC-DEA Document 340 Filed 01/25/23 Page 2 of…#x27; Orexo no longer asserts the ‘010 or ‘388 patents, (Orexo’s Second Amended Opening Markman Brief, | External link to document |
2023-07-12 | 426 | Opinion | (the “asserted patents”). (ECF No. 352.) U.S. Patent No. 8,940,330 (“the ’330 patent”) is in the same…the ’198 patent, ’330 patent, ’361 patent, ’421 patent, ’900 patent, ’661 patent, ’010 patent, ’387 patent…covered by U.S. Patent Nos. 9,439,900 (“the ’900 patent”) and 11,020,387 (“the ’387 patent”), which, among…of the ’387 patent is dependent on claim 1 of the ’387 patent. Claim 1 of the ’387 patent states: …of the ’387 patent is dependent on Claim 8 of the ’387 patent. Claim 8 of the ’387 patent states: | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |